Unknown

Dataset Information

0

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model.


ABSTRACT: General DNA hypomethylation is associated with Alzheimer's disease (AD), but it is unclear when DNA hypomethylation starts or plays a role in AD pathology or whether DNA re-methylation would rescue early amyloid-related cognitive impairments. In an APP transgenic mouse model of AD-like amyloid pathology we found that early intraneuronal amyloid beta build-up is sufficient to unleash a global and beta-site amyloid precursor protein cleaving enzyme 1 (bace-1) DNA demethylation in AD-vulnerable brain regions. S-adenosylmethionine administration at these early stages abolished this hypomethylation, diminished the amyloid pathology and restored cognitive capabilities. To assess a possible human significance of findings, we examined the methylation at 12 CpGs sites in the bace-1 promoter, using genome-wide DNA methylation data from 740 postmortem human brains. Thus, we found significant associations of bace-1 promoter methylation with ?-amyloid load among persons with AD dementia, and PHFtau tangle density. Our results support a plausible causal role for the earliest amyloid beta accumulation to provoke DNA hypomethylation, influencing AD pathological outcomes.

SUBMITTER: Do Carmo S 

PROVIDER: S-EPMC5041108 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model.

Do Carmo Sonia S   Hanzel Cecilia E CE   Jacobs Marie L ML   Machnes Ziv Z   Iulita M Florencia MF   Yang Jingyun J   Yu Lei L   Ducatenzeiler Adriana A   Danik Marc M   Breuillaud Lionel S LS   Bennett David A DA   Szyf Moshe M   Cuello A Claudio AC  

Scientific reports 20160929


General DNA hypomethylation is associated with Alzheimer's disease (AD), but it is unclear when DNA hypomethylation starts or plays a role in AD pathology or whether DNA re-methylation would rescue early amyloid-related cognitive impairments. In an APP transgenic mouse model of AD-like amyloid pathology we found that early intraneuronal amyloid beta build-up is sufficient to unleash a global and beta-site amyloid precursor protein cleaving enzyme 1 (bace-1) DNA demethylation in AD-vulnerable bra  ...[more]

Similar Datasets

| S-EPMC6774262 | biostudies-literature
| S-EPMC6642011 | biostudies-literature
| S-EPMC6935751 | biostudies-literature
| S-EPMC7031139 | biostudies-literature
| S-EPMC8664832 | biostudies-literature
| S-EPMC6744477 | biostudies-literature
| S-EPMC5558238 | biostudies-other
| S-EPMC7576297 | biostudies-literature
| S-EPMC4593589 | biostudies-literature
| S-EPMC5595697 | biostudies-literature